Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.9M | Sell |
249,611
-56,500
| -18% | -$13.3M | 0.02% | 558 |
|
|
2026
Q1 | $61.1M | Sell |
306,111
-1,760
| -0.6% | -$348K | 0.02% | 591 |
|
|
2025
Q4 | $58.2M | Buy |
307,871
+339
| +0.1% | +$65.1K | 0.02% | 592 |
|
|
2025
Q3 | $54.5M | Sell |
307,532
-265
| -0.1% | -$39.4K | 0.02% | 599 |
|
|
2025
Q2 | $35M | Buy |
307,797
+19,832
| +7% | +$2.12M | 0.01% | 674 |
|
|
2025
Q1 | $30.3M | Sell |
287,965
-1,087
| -0.4% | -$123K | 0.01% | 732 |
|
|
2024
Q4 | $31M | Buy |
289,052
+15,160
| +6% | +$1.71M | 0.01% | 744 |
|
|
2024
Q3 | $27.4M | Buy |
273,892
+3,668
| +1% | +$369K | 0.01% | 762 |
|
|
2024
Q2 | $22.8M | Buy |
270,224
+34,320
| +15% | +$2.73M | 0.01% | 783 |
|
|
2024
Q1 | $17.2M | Buy |
235,904
+50,007
| +27% | +$3.69M | 0.01% | 856 |
|
|
2023
Q4 | $13.3M | Buy |
185,897
+49,668
| +36% | +$2.93M | 0.01% | 908 |
|
|
2023
Q3 | $8.16M | Buy |
136,229
+40,958
| +43% | +$2.7M | 0.01% | 906 |
|
|
2023
Q2 | $6.87M | Sell |
95,271
-1,231
| -1% | -$92.4K | ﹤0.01% | 1124 |
|
|
2023
Q1 | $7.1M | Buy |
96,502
+45,975
| +91% | +$3.27M | ﹤0.01% | 1097 |
|
|
2022
Q4 | $3.38M | Sell |
50,527
-27,392
| -35% | -$1.78M | ﹤0.01% | 1384 |
|
|
2022
Q3 | $4.19M | Sell |
77,919
-2,326
| -3% | -$137K | ﹤0.01% | 1279 |
|
|
2022
Q2 | $4.47M | Sell |
80,245
-1,354
| -2% | -$76.8K | ﹤0.01% | 1347 |
|
|
2022
Q1 | $5.73M | Sell |
81,599
-32,814
| -29% | -$2.38M | ﹤0.01% | 1354 |
|
|
2021
Q4 | $11M | Buy |
114,413
+15,332
| +15% | +$1.42M | 0.01% | 1065 |
|
|
2021
Q3 | $8.61M | Sell |
99,081
-21,301
| -18% | -$1.65M | ﹤0.01% | 1221 |
|
|
2021
Q2 | $9.85M | Sell |
120,382
-12,483
| -9% | -$1.04M | ﹤0.01% | 1195 |
|
|
2021
Q1 | $12.6M | Sell |
132,865
-3,507
| -3% | -$332K | 0.01% | 1081 |
|
|
2020
Q4 | $8.46M | Buy |
136,372
+1,576
| +1% | +$89.8K | 0.01% | 1111 |
|
|
2020
Q3 | $8.02M | Sell |
134,796
-28,748
| -18% | -$1.96M | 0.01% | 1055 |
|
|
2020
Q2 | $11.4M | Buy |
163,544
+9,696
| +6% | +$615K | 0.01% | 919 |
|
|
2020
Q1 | $6.98M | Buy |
153,848
+29,851
| +24% | +$1.69M | 0.01% | 1074 |
|
|
2019
Q4 | $8.07M | Buy |
123,997
+28,620
| +30% | +$1.91M | 0.01% | 1200 |
|
|
2019
Q3 | $5.92M | Buy |
95,377
+17,805
| +23% | +$1.12M | ﹤0.01% | 1302 |
|
|
2019
Q2 | $5.52M | Sell |
77,572
-22,303
| -22% | -$1.64M | ﹤0.01% | 1748 |
|
|
2019
Q1 | $7.83M | Sell |
99,875
-108,406
| -52% | -$8.21M | ﹤0.01% | 1542 |
|
|
2018
Q4 | $17.6M | Sell |
208,281
-103,586
| -33% | -$11M | 0.01% | 955 |
|
|
2018
Q3 | $53.4M | Sell |
311,867
-577,517
| -65% | -$87.1M | 0.03% | 634 |
|
|
2018
Q2 | $115M | Buy |
889,384
+214,170
| +32% | +$23.9M | 0.06% | 343 |
|
|
2018
Q1 | $69.6M | Sell |
675,214
-80,124
| -11% | -$7.92M | 0.03% | 518 |
|
|
2017
Q4 | $64.5M | Sell |
755,338
-68,029
| -8% | -$5.9M | 0.04% | 452 |
|
|
2017
Q3 | $69.9M | Sell |
823,367
-92,053
| -10% | -$7.29M | 0.05% | 424 |
|
|
2017
Q2 | $69.3M | Sell |
915,420
-14,508
| -2% | -$1.01M | 0.05% | 428 |
|
|
2017
Q1 | $61.4M | Buy |
929,928
+114,209
| +14% | +$7.51M | 0.05% | 436 |
|
|
2016
Q4 | $51.7M | Buy |
815,719
+66,512
| +9% | +$4.2M | 0.04% | 482 |
|
|
2016
Q3 | $47.7M | Buy |
749,207
+37,318
| +5% | +$2.74M | 0.03% | 539 |
|
|
2016
Q2 | $53M | Sell |
711,889
-11,633
| -2% | -$863K | 0.04% | 500 |
|
|
2016
Q1 | $48.3M | Buy |
723,522
+95,848
| +15% | +$5.83M | 0.04% | 512 |
|
|
2015
Q4 | $42.5M | Sell |
627,674
-6,405
| -1% | -$395K | 0.03% | 583 |
|
|
2015
Q3 | $33.9M | Buy |
634,079
+133,909
| +27% | +$8.13M | 0.03% | 630 |
|
|
2015
Q2 | $31.5M | Sell |
500,170
-2,766
| -0.5% | -$151K | 0.02% | 720 |
|
|
2015
Q1 | $24.2M | Sell |
502,936
-24,236
| -5% | -$929K | 0.02% | 830 |
|
|
2014
Q4 | $17.5M | Sell |
527,172
-50,993
| -9% | -$1.66M | 0.01% | 1083 |
|
|
2014
Q3 | $16.9M | Buy |
578,165
+439,988
| +318% | +$14.6M | 0.01% | 1027 |
|
|
2014
Q2 | $5.37M | Buy |
138,177
+32,748
| +31% | +$1.33M | ﹤0.01% | 1768 |
|
|
2014
Q1 | $4.42M | Sell |
105,429
-94,019
| -47% | -$3.92M | ﹤0.01% | 1905 |
|
|
2013
Q4 | $6.54M | Sell |
199,448
-473,115
| -70% | -$15.4M | ﹤0.01% | 1580 |
|
|
2013
Q3 | $18.2M | Sell |
672,563
-33,980
| -5% | -$956K | 0.01% | 945 |
|
|
2013
Q2 | $16.5M | Buy |
+706,543
| New | +$12.7M | 0.01% | 953 |
|
Other funds holding LGND
JT
CAM
Deutsche Bank's LGND Position: Q2 2026 in Review
Deutsche Bank reduced its Ligand Pharmaceuticals (LGND) stake by 18% in Q2 2026, selling an estimated $13.3M and leaving 249,611 shares worth $78.9M. The position accounts for 0.02% of the portfolio, ranked #558.
Deutsche Bank first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $115M in Q2 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Deutsche Bank held 249,611 shares of Ligand Pharmaceuticals worth $78.9M as of Q2 2026.
- Deutsche Bank sold 56,500 Ligand Pharmaceuticals shares in Q2 2026, an estimated $13.3M.
- Ligand Pharmaceuticals made up 0.02% of Deutsche Bank's portfolio in Q2 2026, its #558 holding.
- Deutsche Bank first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Ligand Pharmaceuticals position peaked at $115M in Q2 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.